Form D · Pharmaceuticals

Corner Therapeutics, Inc.

Watertown, MA · CIK 0002019875

Offering snapshot reported Oct 20, 2025 · SEC filing

Reported sold
$16.8M
Offering amount: $16.8M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 26, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 20, 2025Initial$16,754,446No comparison4SEC filing
Aug 11, 2025Amendment$58,510,656No comparison14SEC filing
Apr 30, 2025Amendment$53,441,210$2,500,000vs Apr 23, 202414SEC filing
Apr 23, 2024Initial$50,941,210No comparison14SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-561421

Source: Form D, filed Oct 20, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Steve Altschuler Director, Executive
Steven Altschuler Director, Executive
Andrew Bellinger Director
Andrew Cornforth Executive
Alan Ezekowitz Director
Nichols Garrett Executive
Jonathan Kagan Director, Executive
Jeffrey Karp Executive
Richard Malley Director
Garrett Nichols Executive
Nick Seaver Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
300 N. Beacon Street Building 39, Suite 202
Watertown, MA, 02472
Phone: 617-701-7014